학술논문

Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021
Document Type
Article
Source
In: Morbidity and Mortality Weekly Report. (Morbidity and Mortality Weekly Report, 14 January 2022, 71(2):52-58)
Subject
Language
English
ISSN
1545861X
01492195